Taiwan - Delayed Quote TWD

Machvision Inc. (3563.TW)

375.50

+34.00

+(9.96%)

At close: 1:30:31 PM GMT+8

Asian Value Stocks Estimated To Be Trading Below Intrinsic Worth April 2025

As global markets navigate a landscape marked by trade uncertainties and monetary policy shifts, Asian indices have shown resilience amidst these challenges. In this environment, identifying stocks that are potentially trading below their intrinsic value can offer investors opportunities to capitalize on market inefficiencies.

Simply Wall St. 2 days ago

3563.TW
+9.96%
Asian Market Insights: Shenzhen New Industries Biomedical Engineering And 2 Other Stocks Estimated Below Fair Value

Amidst global economic uncertainties and fluctuating indices, the Asian markets have shown resilience, with China's stimulus hopes driving a recent uptick in mainland stock exchanges. As investors navigate these complex conditions, identifying undervalued stocks becomes crucial for those looking to capitalize on potential market inefficiencies.

Simply Wall St. last month

3563.TW
+9.96%
3 Stocks Estimated To Be Up To 48.3% Below Intrinsic Value

As global markets navigate the complexities of trade tensions and fluctuating economic indicators, investors are keenly observing how these developments impact stock valuations. With major indices experiencing mixed performances amid tariff uncertainties and evolving monetary policies, the search for undervalued stocks becomes particularly relevant. In such a climate, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors looking to...

Simply Wall St. 2 months ago

EADSF

EADSY

3563.TW
+9.96%

Performance Overview

Return	3563.TW	TSEC CAPITALIZATION WEIGHTED ST (^TWII)
YTD	-5.18%	-14.74%
1-Year	-0.23%	+0.20%
3-Year	+116.46%	+15.35%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Machvision Inc. (3563.TW)

Asian Value Stocks Estimated To Be Trading Below Intrinsic Worth April 2025

Asian Market Insights: Shenzhen New Industries Biomedical Engineering And 2 Other Stocks Estimated Below Fair Value

3 Stocks Estimated To Be Up To 48.3% Below Intrinsic Value

Performance Overview